Page 98 - Interactive Theoritical Notes of Bioharmaceutics and pharamcokinetics.docx compressed
P. 98
PharmD clinical pharmacy program Level 3, Semester 2 Biopharmaceutics & Pharmacokinetics (PT608(
2. Hepatic metabolism
➢ All drugs that are absorbed from the stomach, small intestine and colon pass into
hepatic portal system and are presented to the liver before reaching the systemic
circulation
• The liver is the primary site of drug metabolism.
• This first pass may result in extensive metabolism of the drug.
• This phenomenon is known as the first pass metabolism and results in decrease
bioavailability of the drug.
➢ The bioavailability of a susceptible drug may be reduced to such an extent as to
▪ Render the GI route of administration ineffective, or to
▪ Necessitate an oral dose which is many times larger than the IV dose,
e.g. propranolol.
➢ Propranolol is well absorbed, but only about 30% of an oral dose is available to the
systemic circulation owing to the first-pass effect.
97